Monashee Investment Management as of Dec. 31, 2023
Portfolio Holdings for Monashee Investment Management
Monashee Investment Management holds 44 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ishares Tr Core S&p500 Etf (IVV) | 21.0 | $119M | 249k | 477.63 | |
| Vanguard Index Fds S&p 500 Etf Shs (VOO) | 20.9 | $118M | 271k | 436.80 | |
| Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA) | 13.1 | $74M | 1.5M | 47.90 | |
| Ishares Tr Core Msci Eafe (IEFA) | 9.7 | $55M | 782k | 70.35 | |
| Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO) | 6.8 | $39M | 943k | 41.10 | |
| Ishares Core Msci Emkt (IEMG) | 5.9 | $33M | 661k | 50.58 | |
| Ishares Tr Core S&p Ttl Stk (ITOT) | 4.0 | $23M | 217k | 105.23 | |
| Vanguard Index Fds Total Stk Mkt (VTI) | 4.0 | $23M | 96k | 237.22 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.4 | $7.8M | 192k | 40.76 | |
| Aercap Holdings Nv SHS (AER) | 1.2 | $6.7M | 90k | 74.32 | |
| PG&E Corporation (PCG) | 0.8 | $4.7M | 260k | 18.03 | |
| Korro Bio (KRRO) | 0.8 | $4.4M | 91k | 47.93 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.7 | $4.0M | 175k | 23.11 | |
| Celldex Therapeutics Com New (CLDX) | 0.7 | $4.0M | 100k | 39.66 | |
| Roivant Sciences SHS (ROIV) | 0.7 | $3.9M | 350k | 11.23 | |
| Argenx Se Sponsored Adr (ARGX) | 0.7 | $3.8M | 10k | 380.43 | |
| Las Vegas Sands (LVS) | 0.7 | $3.7M | 75k | 49.21 | |
| Gossamer Bio (GOSS) | 0.6 | $3.2M | 3.5M | 0.91 | |
| Ambrx Biopharma | 0.5 | $3.0M | 208k | 14.24 | |
| Immunovant (IMVT) | 0.5 | $2.9M | 70k | 42.13 | |
| Springworks Therapeutics (SWTX) | 0.5 | $2.7M | 74k | 36.50 | |
| Permian Resources Corp Class A Com (PR) | 0.4 | $2.4M | 176k | 13.60 | |
| Fluence Energy Com Cl A (FLNC) | 0.4 | $2.4M | 100k | 23.85 | |
| Vaxcyte (PCVX) | 0.4 | $2.4M | 38k | 62.80 | |
| Vesta Real Estate Corp Ads (VTMX) | 0.4 | $2.2M | 55k | 39.62 | |
| Kinetik Holdings Com New Cl A (KNTK) | 0.4 | $2.2M | 65k | 33.40 | |
| Klaviyo Com Ser A (KVYO) | 0.3 | $1.9M | 69k | 27.78 | |
| Aura Biosciences (AURA) | 0.3 | $1.8M | 198k | 8.86 | |
| Hci (HCI) | 0.3 | $1.7M | 20k | 87.40 | |
| Corebridge Finl (CRBG) | 0.3 | $1.6M | 75k | 21.66 | |
| 89bio (ETNB) | 0.3 | $1.6M | 140k | 11.17 | |
| Runway Growth Finance Corp (RWAY) | 0.2 | $1.2M | 92k | 12.62 | |
| Alpine Immune Sciences | 0.2 | $964k | 75k | 12.89 | |
| Myriad Genetics (MYGN) | 0.2 | $957k | 50k | 19.14 | |
| Compass Therapeutics (CMPX) | 0.1 | $780k | 500k | 1.56 | |
| Shattuck Labs (STTK) | 0.1 | $713k | 100k | 7.13 | |
| An2 Therapeutics (ANTX) | 0.1 | $697k | 34k | 20.49 | |
| Bluebird Bio (BLUE) | 0.1 | $690k | 500k | 1.38 | |
| Wave Life Sciences SHS (WVE) | 0.1 | $522k | 103k | 5.05 | |
| Molecular Templates Com New (MTEM) | 0.1 | $455k | 122k | 3.73 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.1 | $293k | 369k | 0.79 | |
| Vivid Seats Com Cl A (SEAT) | 0.0 | $190k | 30k | 6.32 | |
| Purecycle Technologies (PCT) | 0.0 | $48k | 12k | 4.05 | |
| Karyopharm Therapeutics (KPTI) | 0.0 | $35k | 132k | 0.26 |
